ArticleBriefings in bioinformatics2026
MuRaL-indel: a deep learning framework for building insertion and deletion mutation rate maps.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Germline short insertions and deletions (INDELs) are pervasive genetic variants that shape genome evolution and contribute to human disease. However, accurately quantifying fine-scale INDEL mutation rates remains challenging due to data limitations and the diversity of INDEL subtypes. Here, we present Mutation Rate Learner for INDELs (MuRaL-indel), a deep learning framework that predicts germline INDEL mutation rates by leveraging long-range sequence context through a U-Net architecture. Using extensive rare variant data from large population cohorts, MuRaL-indel generates base-resolution, length-specific mutation rate maps for the human genome, and achieves superior accuracy compared with existing models across multiple genomic scales. We successfully apply MuRaL-indel to three non-human species (Macaca mulatta, Drosophila melanogaster, and Arabidopsis thaliana), demonstrating its broad applicability across taxa. Using the predicted mutation rate maps, we reveal the mutational landscape around human coding genes and show that MuRaL-indel-derived constraint scores better prioritize pathogenic INDELs than previous models. Through deep learning interpretability analyses, we uncovered sequence motifs-including both repeat and non-repeat elements-associated with elevated INDEL mutability, providing insights into underlying mutational mechanisms. Together, MuRaL-indel establishes a generalizable and scalable framework for building high-resolution INDEL mutation rate maps, offering a valuable resource for studies of genome evolution, mutational mechanism, variant interpretation, and genetic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.